
Edward Raymond
Examiner (ID: 19266, Phone: (571)272-2221 , Office: P/2857 )
| Most Active Art Unit | 2857 |
| Art Unit(s) | 2857 |
| Total Applications | 1533 |
| Issued Applications | 1393 |
| Pending Applications | 52 |
| Abandoned Applications | 93 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11031608
[patent_doc_number] => 20160228563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'LIPIDATED PEPTIDES FOR LOWERING BLOOD GLUCOSE'
[patent_app_type] => utility
[patent_app_number] => 15/138631
[patent_app_country] => US
[patent_app_date] => 2016-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19317
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15138631
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/138631 | Lipidated peptides for lowering blood glucose | Apr 25, 2016 | Issued |
Array
(
[id] => 12286204
[patent_doc_number] => 09932390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Compositions comprising the NC2 domain of collagen IX and methods of using same
[patent_app_type] => utility
[patent_app_number] => 15/132453
[patent_app_country] => US
[patent_app_date] => 2016-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13851
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15132453
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/132453 | Compositions comprising the NC2 domain of collagen IX and methods of using same | Apr 18, 2016 | Issued |
Array
(
[id] => 15913055
[patent_doc_number] => 10653749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Targeting GIV-GEF-GI signaling for treating diverse diseases
[patent_app_type] => utility
[patent_app_number] => 15/565192
[patent_app_country] => US
[patent_app_date] => 2016-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 37440
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565192
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/565192 | Targeting GIV-GEF-GI signaling for treating diverse diseases | Apr 14, 2016 | Issued |
Array
(
[id] => 16268830
[patent_doc_number] => 20200270317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => POLYPEPTIDES WITH PHASE TRANSITION, TRIBLOCK POLYPEPTIDES OF THE POLYPEPTIDE-CALMODULIN-POLYPEPTIDE WITH MULTI-STIMULI RESPONSIVENESS, HYDROGEL OF THE TRIBLOCK POLYPEPTIDES, AND ITS USES
[patent_app_type] => utility
[patent_app_number] => 15/744210
[patent_app_country] => US
[patent_app_date] => 2016-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744210
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744210 | Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses | Apr 6, 2016 | Issued |
Array
(
[id] => 13803799
[patent_doc_number] => 10179160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-15
[patent_title] => Therapeutic compositions for the treatment of dry eye disease
[patent_app_type] => utility
[patent_app_number] => 15/083907
[patent_app_country] => US
[patent_app_date] => 2016-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 26729
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15083907
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/083907 | Therapeutic compositions for the treatment of dry eye disease | Mar 28, 2016 | Issued |
Array
(
[id] => 11270503
[patent_doc_number] => 20160333049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/074794
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 79796
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15074794
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/074794 | Peptidomimetic macrocycles and uses thereof | Mar 17, 2016 | Issued |
Array
(
[id] => 11641024
[patent_doc_number] => 09662374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Hemostatic compositions'
[patent_app_type] => utility
[patent_app_number] => 15/048647
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11042
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15048647
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/048647 | Hemostatic compositions | Feb 18, 2016 | Issued |
Array
(
[id] => 13276491
[patent_doc_number] => 10149811
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => Methods and compositions for stimulating collagen synthesis in skin cells
[patent_app_type] => utility
[patent_app_number] => 15/041602
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4703
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15041602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/041602 | Methods and compositions for stimulating collagen synthesis in skin cells | Feb 10, 2016 | Issued |
Array
(
[id] => 11018141
[patent_doc_number] => 20160215093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'STABLE HELICAL IONIC POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/006118
[patent_app_country] => US
[patent_app_date] => 2016-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 88
[patent_no_of_words] => 53125
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15006118
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/006118 | Stable helical ionic polypeptides | Jan 25, 2016 | Issued |
Array
(
[id] => 12137054
[patent_doc_number] => 20180015137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'ANTI-SENESCENCE COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/545794
[patent_app_country] => US
[patent_app_date] => 2016-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 29329
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545794
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545794 | Anti-senescence compounds and uses thereof | Jan 24, 2016 | Issued |
Array
(
[id] => 11016790
[patent_doc_number] => 20160213743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'SYNTHETIC APELIN FATTY ACID CONJUGATES WITH IMPROVED HALF-LIFE'
[patent_app_type] => utility
[patent_app_number] => 14/996418
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21322
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14996418
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/996418 | Synthetic apelin fatty acid conjugates with improved half-life | Jan 14, 2016 | Issued |
Array
(
[id] => 11038863
[patent_doc_number] => 20160235818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'Treatment of Pediatric Type 2 Diabetes Mellitus Patients'
[patent_app_type] => utility
[patent_app_number] => 14/995910
[patent_app_country] => US
[patent_app_date] => 2016-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 29942
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14995910
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/995910 | Treatment of Pediatric Type 2 Diabetes Mellitus Patients | Jan 13, 2016 | Abandoned |
Array
(
[id] => 13077075
[patent_doc_number] => 10058592
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Long-acting peptide analogs
[patent_app_type] => utility
[patent_app_number] => 14/995078
[patent_app_country] => US
[patent_app_date] => 2016-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 6093
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14995078
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/995078 | Long-acting peptide analogs | Jan 12, 2016 | Issued |
Array
(
[id] => 12960238
[patent_doc_number] => 09872882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Aurantiamide dipeptide derivatives for treatment or prevention of angiogenesis-related diseases
[patent_app_type] => utility
[patent_app_number] => 14/981178
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 5433
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14981178
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/981178 | Aurantiamide dipeptide derivatives for treatment or prevention of angiogenesis-related diseases | Dec 27, 2015 | Issued |
Array
(
[id] => 12904726
[patent_doc_number] => 20180193417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/577906
[patent_app_country] => US
[patent_app_date] => 2015-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577906
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/577906 | ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE | Dec 8, 2015 | Abandoned |
Array
(
[id] => 11857805
[patent_doc_number] => 09737472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Light-absorbing compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/961678
[patent_app_country] => US
[patent_app_date] => 2015-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 30359
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14961678
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/961678 | Light-absorbing compositions and methods of use | Dec 6, 2015 | Issued |
Array
(
[id] => 12976672
[patent_doc_number] => 20170340989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => TARGET MOLECULE CAPTURE FROM CRUDE SOLUTIONS
[patent_app_type] => utility
[patent_app_number] => 15/536324
[patent_app_country] => US
[patent_app_date] => 2015-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536324
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/536324 | Target molecule capture from crude solutions | Nov 17, 2015 | Issued |
Array
(
[id] => 12137065
[patent_doc_number] => 20180015148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESISTANCE'
[patent_app_type] => utility
[patent_app_number] => 15/524094
[patent_app_country] => US
[patent_app_date] => 2015-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 8143
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524094
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/524094 | DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESISTANCE | Nov 2, 2015 | Abandoned |
Array
(
[id] => 14551255
[patent_doc_number] => 10344069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-09
[patent_title] => Process for the preparation of liraglutide
[patent_app_type] => utility
[patent_app_number] => 15/523384
[patent_app_country] => US
[patent_app_date] => 2015-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5042
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523384
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/523384 | Process for the preparation of liraglutide | Oct 30, 2015 | Issued |
Array
(
[id] => 10769048
[patent_doc_number] => 20160115204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/921573
[patent_app_country] => US
[patent_app_date] => 2015-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21999
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14921573
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/921573 | METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS | Oct 22, 2015 | Abandoned |